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Abstract The Yin-Yang 2 (YY2) protein is the most recently
described member of the family of YY transcription factors.
Despite its high structural and functional homology with the
well-characterized YY1, less is known about its role in bio-
logical processes. In previous studies, we have found differ-
ential yy2mRNA expression levels in various cell types of the
murine brain. To investigate the functional implication of yy2
in neurons, we have examined the influence of altered cellular
yy2 concentrations during neuronal differentiation. Our re-
sults indicate that both the up- and down-regulation of yy2
significantly impairs the outgrowth of the major neurite of
primary hippocampal neurons and the numbers of neuronal
processes in proximate extensions. Moreover, enhanced ex-
pression of wild-type yy2 results in increased cell death,
whereas elevated expression levels of a yy2 DNA-binding
mutant have no effect on cell viability. Therefore, stringent
regulation of the cellular yy2 content might be needed to en-
sure proper neurite outgrowth and cell vitality.
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Introduction
During brain development, exact temporal and spatial regula-
tion of cellular processes are essential for the proper functional
maturation of neuronal connectivities. Neurite outgrowth, ax-
onal guidance, and dendritic development, all of which occur
during neuronal differentiation, are crucial cellular events for
the establishment of the neuronal network (da Silva and Dotti
2002). In this context, primary cultured hippocampal neurons
are a well-characterized system for studying the molecular
mechanisms that regulate changes of neurite morphology
(Dent et al. 2004; Schwamborn et al. 2006). In vitro, specific
stages of neuronal differentiation are characterized by the fol-
lowing morphological characteristics: after attaching to the
substrate neurons form lamellipodia (stage 1), and within a
few hours several short undifferentiated processes of similar
length, called neurites, are formed (stage 2). After 24–48 h,
one of these neurites is selected to become the axon and begins
to elongate rapidly, whereas the length of the other neurites is
not substantially changed (stage 3). Several days later, the
remaining neurites begin to grow and differentiate into den-
drites (stage 4). The axon and dendrites then reach maturation,
and the neurons form synaptic contacts (stage 5; Dotti et al.
1988). The transformation from stage 2 to stage 3 is the crucial
step in neuronal differentiation when one neurite becomes the
axon, and thereby, the neuron acquires a polar morphology.
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This process involves the coordinated assembly and activation
of a number of signaling molecules and their transcriptional
regulatory downstream targets to control axon specification.
The biological impact of the transcription factor Yin-Yang
1 (YY1) in neurogenesis has been intensively studied (He and
Casaccia-Bonnefil 2008). However, a distinct functional im-
plication of its homologYY2 in neuronal development has not
yet been described. YY2 shares a variety of structural and
functional similarities with YY1. Both proteins recognize an
identical DNA-binding element with a highly conserved
C-terminal C2H2-zinc finger domain (Kim et al. 2007;
Luo et al. 2006; Nguyen et al. 2004). Once bound to
DNA, these transcription factors can act as activators or
repressors (Usheva and Shenk 1996). Depending on the
particular target gene, both YY-proteins can mediate ei-
ther identical or contrary transcriptional activities (Chen
et al. 2010; Klar and Bode 2005).
Without specific antibodies against mouse yy2, the cellular
content of this protein was initially estimated by analyzing the
content of yy2 mRNA. At first, the differential expression
pattern of yy2 mRNA in the brain was visualized by in situ
hybridization techniques (Luo et al. 2006). For a better under-
standing of the region- or cell-type-specific yy2 expression,
we performed quantitative polymerase chain reaction
(qPCR) expression analyses in the developing murine brain
and in neurons, astrocytes, and microglia (Drews et al. 2009).
Thereby, we identified spatial and temporal differences
in yy2 expression levels in the neocortex and cerebel-
lum, supporting the specific regulatory functions of yy2
within these tissues at particular developmental stages.
Moreover, we found lower yy2 levels in neurons, com-
pared with astrocytes or microglia.
In our present study, we show that the length of the major
neurite is directly deregulated by knockdown or overexpres-
sion of the cellular yy2 expression. Furthermore, yy2 overex-
pression influences the number of neuronal processes in prox-
imate extensions. We have evidence that cofactors are essen-
tially involved in this process. Our experiments imply a func-
tional role of yy2 for proper neurite development.
Materials and methods
Animals
Pregnant, postnatal, and adult C57BL/6 mice, obtained from
our central animal facility, were kept under standard laborato-
ry conditions (12 h light/dark cycle; 55±15 % humidity; 24±
2 °C room temperature [RT] and water ad libidum) in accor-
dance with German and European guidelines (2010/63/EU)
for the use of laboratory animals. Approval of experiments
was obtained from the local ethical committee of Berlin
(LAGeSO: T0108/11).
Plasmid construction
The mouse yy2 coding sequence (NCBI accession no.
EF688658) was cloned via the XhoI and BamHI restriction
sites into the pCLEG expression vector (Chen et al. 2005).
The mouse yy2-FLAG expression plasmid was generated by
insertion of a FLAG-linker (5′-cat gga cta caa gga cga cga tga
caa gag atc tt-3′ and 5′-cta gaa gat ctc ttg tca tcg tcg tcc ttg tag
tcc atg ggc c-3′) into pcDNA3.1(−)muyy2 (Klar and Bode
2005) via ApaI and XbaI restriction sites. The mouse yy1
coding sequence (NCBI accession no. NM_009537) was
cloned via BamHI and EcoRI restriction sites into the eukary-
otic expression vector pcDNA3.1(−). The resulting plasmids
pCLEGmyy 2 , p cDNA3 . 1 (− ) F LAGmyy 2 , a n d
pcDNA3.1(−)myy1 were subsequently verified by sequenc-
ing analysis. The yy2 DNA-binding mutant comprising a
T312A substitution, derived from human YY1 mutant
T348D (Rizkallah and Hurt 2009), was generated by site-
directed mutagenesis with pCLEGmyy2 and the following
primer pair: 5′-cag ctt gtt cac gct gga gag aaa cc-3′ and 5′-
ggt ttc tct cca gcg tga aca agc tg-3′. Correct amplification was
confirmed by Sanger sequencing. For transient knockdown
analyses of murine yy2, three different short hairpin RNA
(shRNA)-expressing plasmids were constructed. The shRNA
sequences were cloned into a BglII/SalI linearized pCGLH
vector (Chen et al. 2005): shRNA-yy2-528 (5′-gat ctc gac
aac cta cta ttc agt cct gtt caa gag aca gga ctg aat agt agg ttg
ttt ttt tgg aac-3′ and 5′-tcg agt tcc aaa aaa aca acc tac tat tca gtc
ctg tct ctt gaa cag gac tga ata gta ggt tgt cga-3′), shRNA-yy2-
539 (5′-gat ctc gtt cag tcc tga att tgg aag ctt caa gag agc ttc caa
att cag gac tga att ttt tgg aac-3′ and 5′-tcg agt tcc aaa aaa ttc agt
cct gaa ttt gga agc tct ctt gaa gct tcc aaa ttc agg act gaa cga-3′),
shRNA-yy2-634 (5′-gat ctc gag aga atg gtc aag gtg agc ttt caa
gag aag ctc acc ttg acc att ctc ttt ttt tgg aac-3′ and 5′-tcg agt tcc
aaa aaa aga gaa tgg tca agg tga gct tct ctt gaa agc tca cct tga cca
ttc tct cga-3′). The numbers in the plasmid nomenclature re-
flect the corresponding position of the first shRNA base pair
within the murine yy2 mRNA sequence (NCBI accession no.
NM_001098723). All insertions were verified by sequencing.
A pCGLH shRNA expression plasmid against luciferase
mRNA (shRNA-luc) was used for control experiments
(Franke et al. 2012).
Hippocampal primary neurons: preparation
and transfection
Hippocampal primary neurons were isolated from mouse em-
bryos at day 18 (E18). Hippocampi from several embryos
were collected, pooled, and washed twice in ice-cold HBSS
(Hank’s buffered salt solution, Life Technologies, Darmstadt,
Germany). The tissue was incubated in 4 ml HBSS and 400 μl
trypsin for 15 min at 37 °C, resuspended in MEM plating
medium supplemented with 10% horse serum, 0.6 % glucose,
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100 U/ml penicillin, and 100 μg/ml streptomycin (all Life
Technologies). After dissociation, neurons were plated for im-
munocytochemical experiments at a density of 100,000 cells/
cm2 onto poly-L-lysine (Sigma-Aldrich, St. Louis, Mo.,
USA)-coated cover slips in 12-well plates. After 3 h, cells
were washed twice with phosphate-buffered saline (1 ×
PBS) and incubated in Neurobasal A medium, supplemented
with 2 % B27, 0.5 mM glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin (all Life Technologies) at 37 °C and
5 % CO2. Primary cells were routinely maintained at 37 °C
with 5 % CO2 in Neurobasal A medium supplemented as
described above. Primary neurons were transfected at division
1 (DIV1) by using Effectene (Qiagen, Hilde, Germany) and
analyzed 48 h later (DIV3).
Immunocytochemistry and microscopy
Primary neurons were fixed 48 h after transfection in ice-cold
4% paraformaldehydewith 15% sucrose in PBS for 10min at
RT, washed three times with 1 × PBS for 10 min, perme-
abilized with 0.1 % Triton X-100, 0.1 % sodium citrate in
PBS for 3 min at 4 °C, washed again three times with 1 ×
PBS for 10 min, and incubated for 1 h with blocking solution,
at RT, containing 10 % FCS in 1 × PBS. Neurons were incu-
bated with primary antibodies overnight at 4 °C and then
washed three times with 1 × PBS for 10 min. Antibodies were
used at the following dilutions: anti-green fluorescent protein
(GFP; AbCam, Cambridge, UK) 1:2500, anti-FLAG (7425;
Sigma-Aldrich) 1:1000, and anti-YY2 (A-5; sc-377008;
mouse monoclonal antibody; Santa Cruz Biotechnology,
Heidelberg, Germany) 1:100 and 1:250, respectively. The sec-
ondary antibodies, namely Alexa Fluor 488 and Alexa Fluor
568 at a dilution of 1:1500, were subsequently applied for
90 min at RT. Slides were mounted with Immu-Mount
(Thermo Fisher Scientific, Waltham, Mass., USA). Confocal
images were acquired with an upright laser microscope (Leica
DM 2500) equipped with a ×63 objective (oil immersion 1.4
NA) and a ×40 objective (oil immersion, 1.25 NA) by using
the 488-nm line of an argon-ion laser and the 543-nm line of a
helium-neon laser. Background correction and adjustment of
brightness and contrast were performed by using Leica con-
focal software. For co-localization studies, z-stacks of both
fluorophores were sequentially acquired and projections
averaged.
Morphological analysis
For morphological analysis, fluorescence images of primary
neurons were acquired with an inverted epifluorescence mi-
croscope (Olympus IX 81) equipped with a ×100 objective
(oil-immersion, 1.3 NA). Images were taken by camera F-
View II (Olympus) by using cellSens DimensionDesktop
Version 1.4.1 (Build 8624) software from Olympus.
Background correction and the adjustment of brightness and
contrast were performed by using Adobe® Photoshop CS 3
software. The length of the longest neurite was measured by
using ImageJ 1.45 s software. Data analysis was performed by
using GraphPad Prism 5 (GraphPad Software, La Jolla, Calif.,
USA) on n=48 for the control (pCLEG empty vector) and yy2
wild-type (wt), n=54 for yy2 mut, n=29 for shRNA-luc, and
n=33 for shRNA-yy2-539. Numbers of primary neurites
emerging from the cell body were calculated. Data analysis
was performed by using GraphPad Prism 5 from n=46 for
control (pCLEG empty vector) and yy2 wt, n=52 for yy2
mut, n=27 for shRNA-luc, and n=31 for shRNA-yy2-539.
The number of neurites was determined by means of Sholl
analysis, by using 24 10-μm-spaced concentric circles with
maximal distances of 250 μm distal to the cell body. The
innermost circle with a radius of 20 μm was placed onto each
neuron, with its center roughly coinciding with the center of
the soma. Neurite intersections at each circle were manually
counted by using ImageJ. Sholl analysis of neurons was per-
formed by using GraphPad Prism 5 on n=48 for control
(pGLEG empty vector) and yy2 wt, n=54 for yy2 mut, n=
29 for shRNA-luc, and n=33 for shRNA-yy2-539. One inves-
tigator, blind to the experimental conditions, performed the
measurement. For all measurements, 3–6 different transfec-
tions were used. The measurement performed in micrometers
or n was converted to a percentage. Data are reported and
presented as means±SEM. Statistical significance was deter-
mined by using the two-tailedMannWhitney test for unpaired
data at the given significance level (P: *** 0.001<P; ** 0.001
<P<0.01; * 0.01<P<0.05).
Cell lines and transfection experiments
N1E-115 mouse neuroblastoma (ATCC CRL-2263), human
embryonic kidney HEK293 (DSMZ no.: ACC 305), and hu-
man cervix carcinoma HELA (DSMZ no.: ACC 57) cells
were grown at 37 °C in a humidified 5 % CO2-enriched at-
mosphere in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10 % fetal bovine serum, 50 U/ml penicil-
lin, and 10mg/ml streptomycin (all PAN-Biotech, Aidenbach,
Germany). For transfection experiments, cells were plated at a
density of 50,000 cells/ml per cm2 onto poly-L-lysine (Sigma-
Aldrich)-coated coverslips in 12-well plates. Next day, the
medium was renewed, and the cells were transfected with
1 μg pCLEG, pCLEG-yy2, or pCLEGmYY2 (T312A) by
using lipofection reagent FuGene 6 (Roche, Mannheim,
Germany) according to manufacturer’s protocol and analyzed
24 h later. Transfection experiments to validate shRNA-
expression constructs were conducted with 200,000 HEK
293 cells per 6-well plate by lipofection with Metafectene
(Biontex, München, Germany). One day after plating, cells
were transfected with 24 μg of the particular pCGLH con-
struct. Next day, cells were transfected with 1 μg of the
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corresponding pCGLH and 1 μg yy2 expression plasmid
pCLEGmyy2, respectively. After 24 h, cells were lyzed in
RIPA buffer (0.05 M TRIS, pH 7.4, 0.15 M NaCl, 0.001 M
EDTA, 0.001 M EGTA, 1 % Triton-X, 0.25 % [Na]DOC).
Ectopic expression of mouse yy2 wild-type and T312 mutant
protein in HELA cells was achieved by using the Metafectene
transfection protocol. At 2 days after transfection with 2 μg
pCLEGmyy2 or pCLEGmyy2 (T312A) plasmid, respectively,
cells were lyzed in RIPA buffer.
Western blot analysis
Whole cell lysates were prepared by lysis in RIPA buffer.Mouse
yy2 and yy1 were in vitro-translated from corresponding
pcDNA3.1(−) expression plasmids by using the TNT-Coupled
Transcription/Translation system (Promega, Mannheim,
Germany) according the manufacturer’s protocol. Whole cell
lysates or in vitro-translated proteins were separated by SDS-
polyacrylamide gel electrophoresis and subsequently transferred
by semi-dry blot technique onto nitrocellulose membranes.
After the membrane had been blocked overnight in 5 % nonfat
dry milk/1 × TBS-T (30 mMTRIS-HCl pH 7.6, 150 mMNaCl,
0.1 % Tween 20), immobilized proteins were detected by using
the following primary and horseradish-peroxidase-conjugated
secondary antibodies: anti-FLAG (Sigma-Aldrich; M2;
1:2000), anti-β-actin (Sigma-Aldrich; 1:5000), anti-GFP
(Abcam, 1:5000), anti-YY1 (sc-281; 1:500), anti-YY2 (sc-
377008; 1:500), anti-mouse (sc-2005; 1:10000), and anti-
rabbit (sc-2004; 1:10,000; all from Santa Cruz Biotechnology).
Visualization was conducted with theWestern Blotting Luminol
Reagent (Santa Cruz Biotechnology).
Propidium iodide staining
Cell survival was analyzed by using the intercalating agent
propidium iodide (PI; Carl Roth, Karlsruhe, Germany). At
24 h after transfection of N1E-115 cells, the culture medium
was replaced with fresh preheated medium containing 5 μg/ml
PI and incubated for 1 h at 37 °C under a humidified 5 % CO2-
enriched atmosphere. Fluorescence images were acquired with
the inverted Olympus IX 81, as described above, but equipped
with a ×20 objective (0.45 NA). Each experiment was carried
out in triplicate and repeated 6–9 times. PI-stained cells were
counted by using ImageJ Gel densitometry software. The per-
centage of dead cells was calculated as a proportion of PI-
positive cells to that of total cells. The amount of total cells per
well were calculated based on the plated cell number. Data anal-
ysis was performed by using GraphPad Prism 5 on n=27 for
control (pCLEG empty vector), n=24 for yy2 wt, and n=52 for
yy2 mut. Data are reported and presented as means±SEM.
Significance was assessed by using the two-tailed Mann
Whitney test for unpaired data at the given significance level
(P: *** 0.001<P; ** 0.001<P<0.01; * 0.01<P<0.05.
Quantitative reverse transcription plus PCR
N1E-115 cells were transiently transfected with empty
pCLEG (control), yy2 wt or yy2 mut expression plasmids.
After 24 h, total RNA was isolated by using the TRIzol pro-
tocol (Life Technologies). Subsequently, 2 μg RNAwere re-
versely transcribed into cDNA and subjected to qPCR analy-
sis by using the following TaqMan Gene Expression Assays
for β-actin (4352933E), yy2 (Mm03059489_sH), bax
(Mm00432051_m1), and bcl2 (Mm00477631_m1; all Life
Technologies).
Results and discussion
YY2 is expressed in immature neurons
Here, we investigated the functional implication of yy2 during
neuronal differentiation by deregulation of the endogenous
yy2 protein content. To date, the yy2 transcription factor has
not been studied in mice at the protein level at all. Thus, we
initially validated the commercially available anti-YY2mouse
monoclonal antibody from Santa Cruz Biotechnology for im-
munoblots and for immunofluorescence microscopy analysis
to visualize altered cellular yy2 concentrations. Because of the
high homology of both yy proteins, especially within the C-
terminal DNA-binding zinc finger domain, some purchasable
antibodies cross-react between both yy transcription factors
(Klar 2010, 2012; Klar and Bode 2005). To establish the spec-
ificity of the monoclonal antibody, we performed immuno-
blots with in vitro-translated yy2 and yy1 proteins. As
depicted in Fig. 1a, the anti-yy2 antibody exclusively detected
yy2, whereas yy1 was only recognized by a specific anti-yy1
antibody. To investigate further the suitability of this anti-yy2
antibody for immunofluorescence, we transfected hippocam-
pal cultured neurons with expression plasmids encoding for
FLAG-tagged yy2 and performed co-localization studies
(Fig. 1b, anti-yy2, b’ anti-FLAG, b’’ merge). This analysis
clearly demonstrated that the yy2 antibody recognized
FLAG-yy2 overexpression in primary neurons.
To examine the effects of an altered cellular content of yy2
in immature neurons, we generated molecular tools for ectopic
expression and knockdown studies of yy2 optimized for de-
tection by fluorescence microscopy. Next to yy2 itself or a
particular shRNA, all constructs constitutively co-expressed
enhanced GFP (eGFP) for the identification of transfected
primary neurons. Unfortunately, the reactivity of commercial-
ly available antibodies against mouse yy2 was not sufficient to
detect the endogenous level of this transcription factor in
whole-cell and nuclear extracts from hippocampal primary
neurons by Western blot analysis. To validate the knockdown
efficiencies of three different shRNA expression constructs,
HEK293 cells were co-transfected with FLAG-tagged mouse
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Fig. 1 Antibody and yy2
knockdown verification. a
Immunoblot (IB) analysis for
testing reactivity and specificity
of the anti-yy2 antibody sc-
377008 by using in vitro-
translated mouse yy1 and yy2,
respectively. Pure reticulocyte
lysate served as control. b, b’, b’’
Primary neurons were transfected
with FLAG-tagged yy2, and
confocal fluorescence
microscopy was conducted with
indicated antibodies. c
Knockdown efficiency test of
three different short hairpin RNA
(shRNA) expression plasmids
directed against mouse yy2 in
HEK293 cells. Co-expression of
FLAG-tagged yy2 was used to
identify knockdown efficiencies
easily. An shRNA expression
plasmid against luciferasemRNA
(shRNA-luc) and the empty vector
construct (control) were used for
control experiments. AWestern
blot against green fluorescent
protein (GFP) was performed to
compare transfection efficiencies
of the shRNA expression
plasmids and the immunological
detection ofβ-actin, which served
as a loading control. d, d’, d’’
Visualization of endogenous yy2
and its efficient knockdown in
primary neurons compared with
non-transfected and control




expression plasmid and yy2 was
conducted by using the indicated
antibodies. The areas in the white
boxes are shown at higher
magnification below the relevant
micrograph (arrow cell of
interest). Bars 50 μm
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yy2. As shown in Fig. 1c, construct shRNA-539 mediated a
significantly reduced expression of FLAG-yy2. Finally, in or-
der to confirm the knockdown capacity of shRNA-539 in
primary neurons, we next targeted cellular yy2 in primary
hippocampal neurons. As depicted in Fig. 1d, d’, d’’, we clear-
ly achieved an efficient knockdown of endogenous yy2,
whereas all non-transfected neurons or control transfected
neurons showed clear nuclear yy2 staining (Fig. 1e, e’, e’’).
Taken together, our data, which were obtained by using a
commercially available anti-yy2 antibody, were able first to
demonstrate the specificity of this antibody and second to
visualize endogenous yy2 and its shRNA-driven transient
knockdown in primary hippocampal neurons.
Changes of endogenous yy2 expression influence primary
neuron differentiation
In early, not yet polarized, hippocampal cultured neurons, we
investigated whether the expression of yy2 influenced neurite
outgrowth. Initial expression control experiments in HELA
cells of both wild-type yy2 (yy2 wt) and a mutant (yy2
mut), which is unable to bind to DNA, revealed proper ectopic
protein production (Fig. 2a). In transiently transfected primary
hippocampal neurons, yy2 overexpression resulted in a de-
crease in the number of neurites projecting to the soma by
20 % (Fig. 2b), whereas overexpression of the mutant yy2
did not show such changes (Fig. 2b). In addition, the number
of neurites projecting to the soma was not significantly altered
by the knockdown of yy2 (Fig. 2c). All these findings implied
that a normal or reduced endogenous yy2 concentration did
not impact the number of neurites formed by a single neuron,
whereas an elevated yy2 level seemed to compete with anoth-
er transcription factor, possibly YY1, for genomic DNA-
binding sites relevant for the regulation of a proper number
of neurites. Of note, the latter observation is reminiscent of the
effects previously published for yy2 in reporter gene analyses.
In these experiments, some gene promoters were activated in
response to lower concentrations of overexpressed yy2,
whereas higher yy2 expression level resulted in decreased
activities of the same promoters (Nguyen et al. 2004). The
transcriptional activities of yy2 have been proposed to be
promoter- and dose-dependent and putatively dependent on
other transcription factors such as yy1.
Moreover, a higher expression level of the yy2 transcrip-
tion factor leads to a decrease in the length of the longest
neurite, which later will become an axon (Dotti et al. 1988).
Here, we have demonstrated that the longest neurite reaches
only 67 % of the length of the control cells (Fig. 2d,
Supplemental Fig. 1a, a’). Interestingly, the overexpression
of the yy2 DNA-binding mutant shows an increase of 36 %
in the length of the longest neurite compared with the control
group (Fig. 2d, Supplemental Fig. 1a’’). Moreover, Sholl anal-
yses also revealed substantially reduced numbers of neuronal
processes in proximate extensions in yy2 wt overexpressing
primary neurons, whereas the yy2 DNA-binding mutant
shows the opposite effect (Fig. 2e, Supplemental Table 1,
supplemental Table 3). However, the knockdown of yy2 also
leads to a 37 % increase of the length of the longest neurite
compared with that of the control cells (Fig. 2f, supplemental
Fig. 1b, b’) but does not show significant changes in neurite
branching (Fig. 2g, Supplemental Table 2). In contrast to the
examinations mentioned above regarding the influence of the
altered yy2 level on the absolute number of neurites, the
length of the major neurite is directly deregulated by changes
of the cellular yy2 content. In particular the enhanced length
growth of neurites observed in the knockdown experiments
underlines the functional role for yy2 during neuron differen-
tiation, whereas a similar effect achieved by the overexpres-
sion of the yy2 DNA-binding mutant suggests that cofactors
are essentially involved in the yy2-mediated control of neurite
length growth. The excess of mutant yy2 seems to subdue the
interaction between DNA-bound yy2 and its interacting pro-
tein partners. So far, only a few yy2-interacting proteins have
been described, namely ring finger protein 1 and 2 (RING1,
RING2) and embryonic ectoderm development (EED), all of
which belong to the family of Polycomb-group (PcG) proteins
(Garcia-Tunon et al. 2011). As PcG proteins are known to play
a fundamental role mainly in gene silencing, we are tempted to
speculate that yy2 is part of this gene regulatory machinery.
Interestingly, knockdown studies of enhancer of zeste 2
(EZH2), which represents next to EED and suppressor of zeste
12 homolog (SUZ12), one of the three core subunits of the
polycomb repressor complex 2 (PRC2; Cao et al. 2002) by
Wang et al. (2012) have shown that a decreased EZH2 level
induces neurite extensions. All these results indicate that
changes in the expression level of yy2 negatively influence
neuronal differentiation processes.
YY2 overexpression leads to neuronal cell death
During our transient yy2 transfection assays in primary hip-
pocampal neurons, we found many obviously degraded cells
when wild-type yy2 was overexpressed (data not shown).
Thus, we asked whether an increase of yy2 expression specif-
ically forces neuronal cell death. By using the neuroblastoma
cell line N1E-115 in order to attain a higher transfection rate
compared with primary neurons, we found that yy2 wt over-
expression significantly increased cell death compared with
that of controls (control=14 %; yy2 wt=34 %; Fig. 2h).
Interestingly, elevated level of yy2 mut had no influence on
cell death (Fig. 2h). Functionally to associate the increased
cell death with apoptosis, we subsequently analyzed, via
qPCR, whether the common (anti-) apoptotic genes Bax and
Bcl2 were deregulated. Although yy2 wt and yy2 mut were
strongly upregulated, both Bax and Bcl2 showed no alter-
ations at all. Thus, the observed wild-type yy2-induced-cell
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Fig. 2 Morphological analyses
of primary neurons with altered
yy2 expression levels. a
Expression control experiments in
HELA cells revealed proper
ectopic protein expression of
wild-type (yy2 wt) and mutant
(yy2 mut) yy2, respectively.
Western blot against β-actin
served as loading control. b, c
Comparison of the number of
neurites per neuron with respect




Investigations on the impact of
yy2 overexpression levels on the
outgrowth of major neurites (d)
and the numbers of neuronal
processes (e) in primary
hippocampal neurons and yy2
knockdown effects on the
outgrowth of the major neurites
(f) and the numbers of neuronal
processes (g). h PI-staining.
Quantification of dead N1E-115
neuroblastoma cells transiently
transfected with yy2 wt and yy2
mut, respectively
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death is not caused by classical apoptosis (Supplemental
Fig. 1c). All these findings indicate that an increased yy2 level
forces cell death in neuronal cells as a consequence of direct
yy2-DNA interaction. We have to assume that an excess of
yy2 competes with other transcription factors for functional
DNA-binding sites of pivotal genes.
In summary, our experiments support a functional role for
yy2 for proper neurite development. A strict regulation of the
cellular yy2 concentrations seems to be needed to ensure nor-
mal neurite outgrowth and cell vitality.
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